Ochrobactrum anthropi, Ochrobactrum intermedium and Brucella spp. are phenotypically and genetically closely related pathogens that may cause disease with similar clinical presentation. Consequently, difficulties in their identification and differentiation have been reported. In this study, a sensitive recA gene-based multi-primer single-target PCR (MP-ST-PCR) was developed that allowed the specific detection and differentiation of these clinically relevant pathogens. The specificity of the assay was evaluated using a representative panel of 50 O. anthropi and 16 O. intermedium strains and the type strains of all Brucella spp. Detection limits for purified DNA from O. anthropi, O. intermedium and Brucella melitensis were 100, 10 and 100 fg, respectively. Brucella DNA was also successfully detected in various clinical specimens from a human patient with culture-proven brucellosis and from a Brucella-infected sheep and its aborted fetuses. The sensitivity of the MP-ST-PCR was comparable to that of an evaluated in-house Brucella real-time PCR assay. The developed assay closes a diagnostic gap and provides a simple but robust tool for the sensitive detection and correct identification of O. anthropi, O. intermedium and Brucella spp.
INTRODUCTION
Ochrobactrum and Brucella are genetically closely related genera of the family Brucellaceae within the class Alphaproteobacteria (Velasco et al., 1998) , with Ochrobactrum intermedium, the closest relative to Brucella, sharing 98.8 % rRNA gene similarity with Brucella spp.
Whereas brucellae are well recognized as important pathogens that cause brucellosis in man and many animal species, Ochrobactrum anthropi and O. intermedium have only recently emerged as human pathogens (Alnor et al., 1994; Möller et al., 1999; Mahmood et al., 2000; Apisarnthanarak et al., 2005; Vaidya et al., 2006; Kämpfer et al., 2007) . In the past, O. anthropi and O. intermedium have been regarded as opportunistic human pathogens of low virulence, infecting only immunocompromised patients with underlying diseases. Recent reports on Ochrobactrum infections, however, have demonstrated the occurrence of severe O. anthropi infections in immunocompetent hosts without underlying diseases with a clinical presentation similar to brucellosis (Kettaneh et al., 2003; Romero Gomez et al., 2004; Perez-Blanco et al., 2005; Ozdemir et al., 2006) . A report on a pelvic abscess in an immunocompetent host and a comprehensive review of the literature on O. anthropi infections in patients with normal immune status was recently published by Vaidya et al. (2006) . Because of the clinical relevance of Brucella infections and the potential use of Brucella as a biological agent (Pappas et al., 2006) , a battery of PCR assays for the specific detection of Brucella spp. has been developed in recent years (Al Dahouk et al., 2004 , 2007 Garcia-Yoldi et al., 2006) . However, in many clinical laboratories, the initial diagnosis is made by conventional identification methods, mainly culture and biochemical analysis using commercially available test systems. These test systems often do not allow correct identification of the agent, and consequently misidentifications of Brucella spp. as O. anthropi (Elsaghir & James, 2003) or O. intermedium (Hubalek et al., 2007) have been reported. Furthermore, as O. anthropi is the only species of Ochrobactrum in the database of commercially available test systems such as API 20NE, differentiation of O. anthropi and O. intermedium is impossible (Teyssier et al., 2005; Kämpfer et al. 2007) . Likewise, O. intermedium was recently misidentified as O. anthropi in a severely diseased patient with a pelvic abscess using the API 20NE test and partial 16S rRNA gene sequencing (Vaidya et al., 2006; Kämpfer et al. 2007) . In this case, partial 16S rRNA gene sequencing was misleading because of the high sequence identity of .98 % between O. anthropi and O. intermedium.
Reports on the misidentification of O. anthropi, O. intermedium and Brucella spp. emphasize the urgent need for a diagnostic tool that allows the correct identification and differentiation of these pathogens. Accordingly, we have developed a sensitive multi-primer single-target PCR (MP-ST-PCR) based on sequence variations in the recA gene that allows the accurate identification and differentiation of O. anthropi, O. intermedium and Brucella spp. in a single reaction.
METHODS
Bacterial strains. A total of 71 Ochrobactrum strains (50 O. anthropi, 16 O. intermedium and one each of Ochrobactrum tritici, Ochrobactrum oryzae, Ochrobactrum grignonense, Ochrobactrum gallinifaecis and Ochrobactrum lupini) and the type strains of the eight Brucella species (Brucella melitensis, Brucella abortus, Brucella suis, Brucella ovis, Brucella canis, Brucella neotomae, Brucella ceti and Brucella pinnipedialis) were examined (Table 1 ). An additional 23 strains of closely related or clinically relevant bacteria were used as a negative-control panel.
Strains were obtained from the American Type Culture Collection (ATCC), the Laboratorium voor Microbiologie (BCCM/LMG), the Culture Collection University of Goeteborg (CCUG), the National Collection of Type Cultures (NCTC), the German Collection of Micro-organisms and Cell Cultures (DSMZ) T were grown at 37 uC in liquid medium to OD 600 0.7 (midexponential growth phase). Genomic DNA was prepared with a DNeasy Blood & Tissue kit (Qiagen) according to the manufacturer's instructions. PCR was carried out as described below.
DNA preparation from clinical samples. Total DNA was prepared from various formalin-inactivated (10 %, v/v) clinical samples and body fluids of an aborting sheep with brucellosis and its two fetuses. Specimens examined were: placental fluid, serum, urine, stomach content, placenta, lung, liver, spleen, uterus, udder and kidney (see Fig. 2(a) , left panel).
Additionally, DNA was prepared from liver biopsy material of a human patient with culture-proven brucellosis. After removing the formalin by washing twice in 10 ml deionized water and further incubation in sterile saline overnight at 4 uC, 50 mg of each sample was homogenized in 500 ml PBS (pH 7.5) using a Bio101 Fast Prep System (Qbiogene). Total DNA was prepared from 100 ml homogenized tissue using a DNeasy Tissue kit (Qiagen). The DNA was eluted twice with 60 ml double-distilled H 2 O, of which 5 ml was used in PCRs.
Primer design and MP-ST-PCR. Primers were designed on the basis of a multi-sequence alignment of known recA gene sequences from Ochrobactrum spp. and Brucella spp. (Scholz et al., 2006; H. C. Scholz, unpublished data) . The GenBank accession numbers of the various recA genes are given in Table 1 . Details of the primers and amplification sizes of the partial recA gene sequences from O. anthropi, O. intermedium and Brucella spp. are given in Table 2. PCR conditions were optimized for each primer pair using purified template DNA from O. anthropi LMG 3331 T , O. intermedium LMG 3301 T and B. melitensis 16M T prior to use in MP-ST-PCR. Optimized MP-ST-PCR was performed in 50 ml Ready-to-go MasterMix (Eppendorf) using 15 pmol each primer. Amplification was carried out in a Perkin-Elmer GeneAmp 2400 thermal cycler with 30 cycles of 30 s denaturation at 94 uC, 40 s annealing at 62 uC and 1 min elongation at 72 uC, with a final elongation step of 7 min at 72 uC. The expected sizes of the amplification products were 544, 402 and 167 bp for O. anthropi, O. intermedium and Brucella spp., respectively. PCR products were separated by 1.5 % (w/v) agarose gel electrophoresis in 16 Tris/borate/EDTA running buffer at a constant voltage of 120 V for 1 h. Fragments were visualized with UV light after staining in ethidium bromide. T were quantified in triplicate using an ND-1000 UV/Vis spectrophotometer (NanoDrop Technologies). The detection limits were determined three times by analysing a dilution series of the prepared DNA in PCR-grade water ranging from 1 ng to 1 fg. In the first step, the detection limit for each primer pair was determined separately using 1 ml of the corresponding template DNA of each T or B. melitensis 16M T was added. Amplification products were analysed by electrophoresis through a 1.5 % agarose gel, followed by ethidium bromide staining and visualization with UV light.
Brucella-specific real-time PCR. An in-house LightCycler realtime PCR was used for the detection of Brucella DNA in clinical samples. This PCR was evaluated recently (Al Dahouk et al., 2007) and uses the specific primers B4/B5, originally developed by Baily et al. (1992) , which targets the omp31 gene of Brucella spp., in combination with Brucella-specific hybridization probes. Briefly, a single-tube duplex LightCycler PCR was performed using a FastStart DNA Hybridization Probes kit (Roche Diagnostics). The 20 ml reaction mixture contained 2.5 mM MgCl 2 , 2 ml 106 reaction mix, 0.5 ml each primer (20 pmol ml 21 ), 0.5 ml each hybridization probe (8 pmol ml 21 ) and 2 ml template DNA. Cycling was started with a 10 min denaturation step at 95 uC, followed by 45 cycles of 10 s denaturation at 95 uC, 10 s annealing at 55 uC and 12 s extension at 72 uC. As an internal amplification control, we included a bacteriophage l PCR system as described previously (Tomaso et al., 2003) . No-template controls containing 2 ml molecular-grade water instead of DNA and positive controls containing Brucella DNA of the reference strains B. melitensis 16M T (biovar 1), B. abortus 1119-3 (biovar 1) and/or B. suis 1330 (biovar 1) were included in each run to detect any amplicon contamination or amplification failure. Temperature transition rates were set at 20 uC s 21 . Fluorescence values were measured during each cycle at 640 and 705 nm. Melting curves were generated by continuous measurement of fluorescence while raising the temperature from 45 to 95 uC with a transition rate of 0.2 uC s 21 . Data analysis was performed using LightCycler software version 3.32. The second-derivative maximum algorithm was used to calculate the cycle threshold (C t ) value. Primer sequences and hybridization probes are listed in Table 2 .
RESULTS AND DISCUSSION
Brucella and Ochrobactrum are phenotypically and genetically closely related micro-organisms that may cause diseases with similar clinical presentation (Elsaghir & James, 2003; Vaidya et al., 2006) . Although Brucella and Ochrobactrum can be differentiated phenotypically by means of their growth behaviour, motility, lysis by Brucella-specific bacteriophages and agglutination with Brucella-specific antisera, misidentification of these organisms using biochemical test systems such as API 20NE has been reported (e.g. Elsaghir & James, 2003; Hubalek et al., 2007) . Currently, no PCR assay is available for the discrimination of O. anthropi, O. intermedium and Brucella spp. Thus, the aim of this study was to establish and evaluate a discriminatory PCR assay for the sensitive and specific detection of each of these pathogens. For this purpose, the recA gene was selected as the target gene, as it is highly conserved between Ochrobactrum and Brucella but exhibits enough stable nucleotide substitutions to establish a discriminatory PCR assay between Ochrobactrum and Brucella and also between O. anthropi, O. intermedium and other non-pathogenic Ochrobactrum spp. (Scholz et al., 2006) . In a recent study, the recA genes of 106 Ochrobactrum strains and the Brucella type strains were However, this was only a theoretical scenario; in practice, it is unlikely that two of these agents, and even less three, would be co-isolated from one patient. However, the multiplex PCR may help to identify laboratory-derived cross-contamination of these organisms.
Brucella DNA from clinical material was detected using an in-house real-time LightCycler PCR that has been evaluated recently (Al Dahouk et al. 2007 ) and compared with the novel MP-ST-PCR described here. Template DNA was prepared from various clinical specimens from a sheep and its fetuses with culture-proven brucellosis (Fig. 2) . Realtime PCR was carried out with template DNA from 31 different clinical samples using 45 cycles of amplification (Fig. 2a) . Template DNAs that were positive in this PCR (nos 2, 4, 6, 8, 9, 10, 11, 17 and 23) were subjected to the MP-ST-PCR using 37 amplification cycles. In this PCR, samples with a C t value of ,37 reacted positively (Fig. 2b , nos 2, 8, 9, 10 and 11). A faint band was visible with template 6 (C t value of 37) in the MP-ST-PCR (Fig. 2b) . 
Differentiation of Ochrobactrum and Brucella
Templates with a C t value of .37 (nos 4, 17 and 23) were negative. Thus, both PCR assays exhibited almost equal detection limits. Brucella DNA was also amplified from liver abscess material from a patient with culture-proven brucellosis (data not shown). . Clinical samples that were used are shown on the left in (a). The numbers of the samples that were positive in the real-time PCR are given on the corresponding amplification curves. Samples with a C t value of ,37 were positive in both PCR assays.
